Genomics Research

We identify biomarkers linked to specific diseases, aiding in early diagnosis, monitoring, and targeted treatment. These discoveries help us develop precision-based therapies and improve patient outcomes.

Phronetik’s researchers focus on identifying genetic mutations and alterations that drive cancer, enabling personalized treatment strategies and risk assessment. Through next-generation sequencing (NGS), biomarker discovery, and functional genomics, we uncover molecular mechanisms that inform targeted therapies, early detection, and individualized patient care for improved outcomes.

Our research focuses on diverse populations to understand genetic variation across different groups. This work addresses health disparities and ensures that genomic insights are relevant to all communities.

Our functional genomics capabilities focus on uncovering how genes regulate biological processes, enabling the development of precision medicine, targeted therapies, and advanced diagnostics. Through transcriptomics, epigenomics, and proteomics, we analyze gene expression, regulation, and protein interactions to identify key molecular pathways associated with disease.

We investigate the genetic causes of rare diseases to provide answers and hope for affected individuals. By pinpointing specific mutations, we aim to open new avenues for treatments and support for these unique conditions.

We integrate DNA/RNA sequencing, genetic marker identification, and bioinformatics to advance crop and livestock resilience, yield, and sustainability. Our expertise supports trait selection, disease resistance, and precision agriculture through advanced genomic analysis. We also contribute to agrigenomic research, applying cutting-edge methodologies to enhance agricultural productivity and adaptation to environmental challenges.